INNOSPEC INC.
No SEC Form 4 filings for $IOSP in the last 30 days.
Innospec (IOSP) discussed Q2 2026 earnings call topics including pricing and cost pass-through in Performance Chemicals, with margins comparable year over year and improved sequentially. The DRA business added capacity, is mostly sold out, and shipped to the Middle East. Q3 is expected similar to Q2, with Fuel Specialties margin pressure from sales mix and some pricing lag.
Innospec (NASDAQ:IOSP) Q2 call: CEO Patrick Williams said Performance Chemicals benefited from operating leverage, Fuel Specialties stayed within targeted margins, and Oilfield Services improved sequentially and YoY on expanded DRA capacity. North Carolina repairs are ~60% complete, with full optimization by Q4. Management expects Q3 segment results broadly similar, plus operating-income growth in H2 2026. Cash from ops was $7.2M before $16.5M capex; $250.2M cash, no debt; repurchased 87k shares
INNOSPEC INC. (IOSP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 iosp-ex99_1.htm EX-99.1 EX-99.1 Innospec REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS Strong contributions from all businesses with revenues up 12 percent and operating income up 16 percent Continued strength in Fuel Specialties and further improvement in Performance C
Over the past 7 days, alphai's AI scored 3 news stories mentioning IOSP (INNOSPEC INC.). Coverage has skewed bullish: 3 bullish, 0 neutral, and 0 bearish.
Recent IOSP coverage spans financial news and earnings.
Management reiterated margin/mix management amid choppy raw-material pricing, while supply constraints limit near-term volume; capacity expansion timing pushes upside into late Q4/early 2027.
Earnings-call guidance and operational repair timeline suggest improving supply and margins, but near-term segment results remain constrained and lagged by input-cost pricing.
The filing provides a fresh earnings datapoint plus balance-sheet and capital return updates, supporting a near-term reassessment of fundamentals and cash flow durability.
Innospec (IOSP) exhibits moderate positive momentum due to dividend increases and share buybacks, but earnings declines suggest caution. Its relevance for trading is limited but noteworthy for small-cap stock strategies.
The insider sale by director Blackmore indicates a potential lack of confidence or liquidity needs, but the concurrent stock price drop suggests broader market or company-specific issues.
alphai scores every news story that mentions IOSP with an AI model for sentiment and relevance, and aggregates insider trades from INNOSPEC INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Innospec (IOSP) discussed Q2 2026 earnings call topics including pricing and cost pass-through in Performance Chemicals, with margins comparable year over year and improved sequentially. The DRA business added capacity, is mostly sold out, and shipped to the Middle East. Q3 is expected similar to Q2, with Fuel Specialties margin pressure from sales mix and some pricing lag.
4 min readInnospec (NASDAQ:IOSP) Q2 call: CEO Patrick Williams said Performance Chemicals benefited from operating leverage, Fuel Specialties stayed within targeted margins, and Oilfield Services improved sequentially and YoY on expanded DRA capacity. North Carolina repairs are ~60% complete, with full optimization by Q4. Management expects Q3 segment results broadly similar, plus operating-income growth in H2 2026. Cash from ops was $7.2M before $16.5M capex; $250.2M cash, no debt; repurchased 87k shares
5 min readINNOSPEC INC. (IOSP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 iosp-ex99_1.htm EX-99.1 EX-99.1 Innospec REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS Strong contributions from all businesses with revenues up 12 percent and operating income up 16 percent Continued strength in Fuel Specialties and further improvement in Performance C
4 min readInnospec Inc. (NASDAQ: IOSP) is highlighted as one of the most popular small-cap stocks, having declared an increased semi-annual dividend of $0.92 per share and a new $75 million share repurchase program. The company reported a 3% YoY revenue increase to $453.2 million in Q1 2026, though adjusted EBITDA and EPS saw declines compared to the previous year. Despite its potential, the article suggests that other AI stocks might offer greater returns in a shorter timeframe.
3 min readInnospec Inc. director Milton C. Blackmore sold 1,030 shares of the company's common stock for $84,296 on February 20, 2026. This transaction occurred amidst a nearly 8% drop in the stock price over the previous week. Concurrently, Blackmore also acquired 1,030 shares through exercising stock options and received 1,539 restricted stock units.
3 min readTop Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
3 min readInnospec (IOSP) delivered earnings and revenue surprises of +8.74% and +0.73%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
2 min readContinued strength in Fuel Specialties offsetting lower than expected results in our other business segments ...
3 min readInnospec Inc's ( NYSE:IOSP ) short interest as a percent of float has risen 36.67% since its last report. According to exchange reported data, there are now 579 thousand shares sold short, which is 3.28% of all regular shares that are available for trading.
2 min readENGLEWOOD, Colo., Oct. 01, 2025 ( GLOBE NEWSWIRE ) -- Innospec Inc. ( NASDAQ: IOSP ) today announced that it will release third quarter 2025 earnings on Tuesday, November 4, 2025 after market close. Following the release of its results, Patrick S.
4 min read
